Physician profile
Sam D Dow
NPI 1265896443
$9,561.07
in general payments reported to CMS, 2019-2025
12 companies · $5,598 in 2025
The $5,598 reported for 2025 was more than what 84% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33.62 · 2021: $632 · 2022: $361 · 2023: $2,147 · 2024: $789 · 2025: $5,598.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,536 · Food and Beverage: $3,999.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,536.00 |
| Food and Beverage | $3,998.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,174.66 | 2023-2025 | Onyx Frontier, Abre, Symplicity G3 |
| Teleflex LLC | $2,744.74 | 2025 | Guideliner, Turnpike |
| Abbott Laboratories | $748.10 | 2022-2025 | Diamondback Coronary, Dragonfly Opstar, Xience Skypoint |
| Terumo Medical Corporation | $632.11 | 2021 | |
| Boston Scientific Corporation | $624.59 | 2019-2025 | Avvigo Guidance System, General - Therapies |
| Shockwave Medical, INC | $556.02 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $477.35 | 2022-2025 | Impella |
| Inari Medical, INC. | $154.87 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Penumbra, INC. | $123.55 | 2024 | Indigo System |
| Biotronik INC. | $118.12 | 2023 | |
| Zoll Circulation INC | $106.19 | 2025 | Therox Ds2 Console, Downstream Cartridge, Catheter |
| Pfizer INC. | $100.77 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sam Dow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.